Pivotal breakthrough achieved through validation of its ability to detect the asymptomatic malaria carriers that sustain transmission, solving the biggest challenge in elimination efforts.

ProtonDx’s Dragonfly diagnostic platform excels in Zambia, further proving its resilience, flexibility and portability and making it ideal for healthcare testing in any environment.

Infectious disease specialist and adventurer Major Scott Pallett pitched his tent 600 km north of the Arctic Circle armed with Dragonfly to put the portable, rapid, multi-pathogen, molecular diagnostic platform to the test.

The POCT-for-Scot evaluation emphasises critical aspects of ProtonDx's diagnostic device that are key for point-of-care settings such as accuracy, portability, user-friendliness, patient comfort, and ease of adoption.

The Tour de France demands quick decisions and immediate health assessments, and this is where Dragonfly, with its rapid testing capabilities, came to the rescue.

ProtonDx's proprietary rapid multipathogen test was a key diagnostic element used to test the Finnish cross-country skiers in the FIS Nordic World Ski Championships in Planica, Slovenia, in February and March 2023.

5-in-1 Respiratory Test Panel from ProtonDx used to assess elite athletes at the 2022 Commonwealth Games.

The Dragonfly Respiratory Diagnostic Panel was utilised by the Team GB clinical staff with great success to test Great Britain's athletes at the 2022 Olympic Winter Games in Beijing.